Document Detail


Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: experimental studies in pigs.
MedLine Citation:
PMID:  8892764     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of echo contrast agents that can provide reliable opacification of the myocardium after intravenous injection is an important advancement for the clinical application of contrast echocardiography. In this study, the hemodynamic effects and echocardiographic characteristics of a new lipid-fluorocarbon echo contrast agent, Aerosomes MRX 115 (ImaRx Pharmaceutical Corp., Tucson, Ariz.) were studied in six anesthetized ventilated pigs. Intravenous injection of this new agent in doses ranging from 0.0005 to 0.01 ml/kg produced significant measurable and visible myocardial opacification without any effect on heart rate, systemic pressure, partial pressure of oxygen, or left ventricular systolic function. The two largest doses (0.005 and 0.01 ml/kg), however, resulted in mild reversible increases in mean pulmonary artery pressure of 12 and 16 mm Hg, respectively. In four animals, epicardial images were obtained before and during coronary artery occlusion. Intravenous contrast injection during coronary occlusion permitted delineation of the hypoperfused myocardial segment. This capability may further expand the utility of contrast echocardiography.
Authors:
S E Grauer; G A Pantely; J Xu; S Ge; G D Giraud; T Shiota; D J Sahn
Related Documents :
1712274 - Vascular protection with cilazapril.
1293314 - Age-related effects of platelet activating factor (paf) in the isolated perfused rat he...
6115724 - Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis...
4079144 - Relationship between perfusion pressure and myocardial microcirculation in the beating ...
6850384 - Effect of cimetidine, hydrocortisone superoxide dismutase and catalase on the developme...
17956984 - Picosecond fluctuating protein energy landscape mapped by pressure temperature molecula...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  132     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1996 Nov 
Date Detail:
Created Date:  1996-12-23     Completed Date:  1996-12-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  938-45     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Oregon Health Sciences University, Portland 97201-3098, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Contrast Media* / pharmacology
Dose-Response Relationship, Drug
Echocardiography / methods*
Fluorocarbons / diagnostic use*,  pharmacology
Heart / drug effects,  radionuclide imaging*
Hemodynamics / drug effects
Swine
Grant Support
ID/Acronym/Agency:
CA-62659-03/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Fluorocarbons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in cor...
Next Document:  Exercise training and heparin pretreatment in patients with coronary artery disease.